Global Human Vaccines Market

Vaccines are the biological products which improves immunity against specific disorder or disease. Vaccines are manufactured from living attenuated organisms, or killed disease-causing microorganism. Vaccination plays an important role to maintain sustainable health of people across various countries. Increase in demand vaccination to treat various diseases is expected to fuel the growth of human vaccines market, in this forecast period.

Increase in prevalence of infectious diseases will increase the demand for vaccines. It is expected to boost the human vaccines market growth. Furthermore, technological advancements in vaccine delivery devices and rise in immunization programs supplement market is expected to propel the growth of global human vaccines market growth. In other hand, rise in government initiatives to create awareness regarding vaccination have the positive impact on global human vaccines market growth.

Get Sample Copy of this Report @

However, storage condition of vaccine is the major restraining factor which expected to hinder the growth of global human vaccines market growth. Also, longer timelines required to vaccine production, and high monetary inputs associated with vaccines will affect the global human vaccines market growth.

Global Human Vaccines Market Segmentation

Global Human Vaccines Market is segmented into technology Conjugate Vaccine, Inactivated & Subunit Vaccines, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine, by Patient Type Paediatric Patients, and Adult Patient, by infection type Pneumococcal Infection, DTP, Influenza, Polio, Rotavirus, and Others. Further, Global Human Vaccines Market is segmented into Route of Administration such as Intramuscular & Subcutaneous, Oral, and Others.

Also, Global Human Vaccines Market is segmented into five regions such as North SAmerica, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Global Human Vaccines Market Key Players

Various key players are discussed in this report such as GlaxoSmithKline PLC, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA,Johnson& Johnson, AstraZeneca, Serum Institute of India Pvt. Ltd., , Daiichi Sankyo Company Limited, Bavarian Nordic, Biological , CSL Limited, and Bharat Biotech.

Global Human Vaccines Market Taxonomy

By Technology

  • Conjugate Vaccine
  • Inactivated & Subunit Vaccines
  • Live Attenuated Vaccine
  • Recombinant Vaccine
  • Toxoid Vaccine

By Patient Type

  • Pediatric Patients
  • Adult Patient

By Infection Type

  • Pneumococcal Infection
  • DTP
  • Influenza
  • Polio
  • Rotavirus
  • Others

By Route of Administration

  • Intramuscular & Subcutaneous
  • Oral
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Browse Full Research Report @

About Us

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.